The Shprintzen-Goldberg syndrome market — addressing an ultra-rare, autosomal dominant connective tissue disorder combining craniosynostosis, a marfanoid body habitus, and intellectual disability — reflects a genuinely fascinating and still-evolving genetic diagnostic story, one where the scientific understanding of the condition's actual cause has meaningfully shifted since the...